Publications by authors named "Jonathan D Low"

Claim this Profile
D
Discovery of a Covalent Inhibitor of KRAS (AMG 510) for the Treatment of Solid Tumors.
Brian A Lanman, Jennifer R Allen, John G Allen, Albert K Amegadzie, Kate S Ashton, Jonathan D Low

J Med Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diastereoselective synthesis of fused cyclopropyl-3-amino-2,4-oxazine β-amyloid cleaving enzyme (BACE) inhibitors and their biological evaluation.
Jonathan D Low, Michael D Bartberger, Yuan Cheng, Doug Whittington, Quifen Xue

Bioorg Med Chem Lett· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D.
Jonathan D Low, Michael D Bartberger, Kui Chen, Yuan Cheng, Mark R Fielden

Medchemcomm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis